Are you a Kogenate® FS patient?
We’re here to support you.
Bayer recently announced that Kogenate FS will be discontinued. We want patients and their caregivers to know that we are here to support you during this transition. However, it's important to work with your healthcare provider as you consider transitioning products.
Click here for the Kogenate FS Discontinuation Announcement from Bayer.
For more information on the Kogenate FS discontinuation click below.
Ready for the next step?
Bayer offers the hemophilia A community additional products, as well as programs and services designed for patients and caregivers. Talk with your doctor about which product might be right for you.
Kogenate FS1 (to be discontinued) | Kovaltry2 | Jivi3 | |
---|---|---|---|
FDA Approval | 1993 | 2016 | 2018 |
Who It's For (indicated age groups) |
Pediatric, adolescent and adult patients (0 - 65+) Pediatric, adolescent and adult patients (0 - 65+) |
Adolescent and adult patients (12 - 65+) Not for use in children under 12 years of age or in previously untreated patients | |
Half-Life |
Standard half-life (SHL) |
Extended half-life (EHL) | |
How It's Dosed (prophylaxis highlights) | Adults/Adolescents: 3 times weekly Children: Every-other-day | Adults/Adolescents: 3 times weekly or twice weekly Children: Every-other-day, 3 times weekly or twice-weekly | Twice-weekly starting dose, with the potential (based on bleeding episodes) to step up to every 5 days and fine tune |
Reconstitution System |
Vial Adapter reconstitution device 25-gauge butterfly needle and pre-filled diluent syringe 25-gauge butterfly needle and pre-filled diluent syringe |
||
Cell Line |
Same type of cell line |
Kovaltry
For children
Learn moreFor adults and adolescents
Learn moreJivi
For adults and adolescents ≥12
Learn more1. Kogenate Prescribing Information. Bayer HealthCare LLC, Whippany, NJ. 2. Kovaltry Prescribing Information. Bayer HealthCare LLC, Whippany, NJ; 2021. 3. Jivi Prescribing Information. Bayer HealthCare LLC, Whippany, NJ; 2018.